Acomhal Research is a biotech startup company that develops novel treatments targeting cancer cells.
Acomhal Research has raised $305K in total funding. The most recent round was Grant. The last funding was announced in January 2022.
Acomhal Research's investors include Virginia Innovation Partnership Corporation, Virginia Tech Carilion (VTC) Innovation Fund, CommonWealth Angels.
Acomhal Research is headquartered in Roanoke, United States.
Acomhal Research is a biotech startup company that develops novel treatments targeting cancer cells.
Acomhal Research is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Acomhal Research — Funding & Investors." VCBacked, January 4, 2022, https://www.vcbacked.co/company/acomhal-research. Accessed September 12, 2026.
VCBacked. (2022). Acomhal Research — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/acomhal-research
{{cite web |title=Acomhal Research — Funding & Investors |url=https://www.vcbacked.co/company/acomhal-research |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated